Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion

Journal of Neuroscience Research

Volumn 45, Issue 1, 1996, Pages 40-56

  Rossner S ^a   Yu, J ^b   Pizzo, D ^b   Werrbach Perez, K ^b   Schliebs, R ^a   Bigl, V ^a   Perez Polo, J R ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

AChE; ChAT; high affinity choline uptake; p75(NFGR); sprouting

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOTOXIN; NERVE GROWTH FACTOR; NEUROMODULIN; SAPORIN; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CELL STRAIN 3T3; CELL TRANSPLANTATION; CEREBROSPINAL FLUID LEVEL; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; FOREBRAIN; GENETIC TRANSFECTION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; RAT;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; CELL TRANSPLANTATION; CEREBRAL VENTRICLES; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC AGENTS; GAP-43 PROTEIN; IMMUNOTOXINS; MALE; MEMBRANE GLYCOPROTEINS; MICE; N-GLYCOSYL HYDROLASES; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; PARASYMPATHETIC NERVOUS SYSTEM; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOPHYSIN;

EID: 0029957824     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960701)45:1<40::AID-JNR4>3.0.CO;2-H     Document Type: Article

References (76)

1. Andrä J, Lojda Z (1986): A histochemical method for the demonstration of acetylcholinesterase activity using semipermeable membranes. Histochemistry 84:575-579.
2. Arendt T, Bigl V, Arendt A, Tennstedt A (1983): Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans, and Korsakof's disease. Acta Neuropath 61:101-108.
3. Bartus RT, Dean RL, Beer B, Lippa AS (1982): The cholinergic hypothesis of geriatric dysfunction. Science 217:408-417.
4. Burke MA, Mobley WC, Cho J, Wiegand SJ, Lindsay RM, Mufson EJ, Kordower JH (1994): Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Exp Neurol 130:178-195.
5. Coyle JT, Price DL, DeLong MR (1983): Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184-1190.
6. Cuello AC, Garofalo L, Kenigsberg F, Maysinger D (1989): Ganglioside potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc Natl Acad Sci USA 86:2056-2060.
7. Dekker AJ, Thal LJ (1992): Effect of delayed treatment with nerve growth factor on acetylcholine transferase activity in the cortex of rats with lesions of nucleus magnocellularis: dose requirements. Brain Res 584:55-63.
8. Dekker AJ, Langdon DJ, Gage FH, Thai LJ (1991): NGF increases acetylcholine release in rats with lesion of nucleus basalis. NeuroReport 2:577-580.
9. Dekker AJ, Gage FH, Thai LJ (1992): Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience 48:111-119.
10. Dekker AJ, Winkler J, Ray J, Thal L, Gage FH (1994): Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 60:299-309.
11. Dowmen M, Mudd L, Roback JD, Palfrey HC, Wainer BH (1993): Early nerve growth factor induced events in developing rat septal neurons. Dev Brain Res 74:1-13.
12. Emerich DF, Winn SR, Harper J, Hammang JP, Baetge AE, Kordower JH (1994): Implants of polymer-encapuslated human NGF-secreting cells in nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 349:148-164.
13. Ernfors P, Ebendal T, Olson L, Mutton P, Stromberg I, Persson H (1989): A cell line producing recombinant NGF evokes growth responses in intrinsic and grafted central cholinergic neurons. Proc Natl Acad Sci USA 86:4756-4760.
14. Fonnum F (1975): A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407-409.
15. Gage FH, Bjorklund A, Stenevi U (1983): Reinnervation of the partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and noradrenergic afferents. Brain Res 268:27-37.
16. Gage FH, Wolf JA, Rosenberg MB, Xu L, Yee JK, Shults C, Friedmann T (1987): Grafting genetically modified cells to the brain: possibilities for the future. Neuroscience 23:795-807.
17. Gage FH, Armstrong DM, Williams LR, Varon S (1988): Morphological responses of axotomized septal neurons to nerve growth factor. J Comp Neurol 269:147-155.
18. Gage FH, Buzsaki G, Armstrong DM (1990): NGF-dependent sprouting and regeneration in the hippocampus. Prog Brain Res 83:357-370.
19. Giacobini E (1994): Therapy of Alzheimer disease: symptomatic or neuroprotective? J Neural Transm (suppl.) 43:211-217.
20. Hagg T, Fassholmes B, Vahlsing HL, Manthorpe M, Conner JM, Varon S (1989): Nerve growth factor (NGF) reverses axotomy-induced decrease in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons. Brain Res 505:29-38.
21. Haroutunian V, Kanof PD, Davis KL (1986): Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor. Brain Res 368:397-399.
22. Haroutunian V, Kanof OD, Davis KL (1989): Attenuation of nucleus basalis Meynert lesion-induced cholinergic deficits by nerve growth factor. Brain Res 487:200-203.
23. Haubrich DR, Chippendale TJ (1977): Regulation of acetylcholine synthesis in nervous tissue. Life Sci 20:1465-1478.
24. Heckers S, Ohtake T, Wiley RG, Lappi DA, Geula C, Mesulam MM (1994): Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci 14:1271-1289.
25. Hefti F (1986): Nerve growth factor promotes survival of septal cho- linergic neurons after fimbrial transections. J Neurosci 6:2155-2162.
26. Hefti F, Dravid A, Hartikka J (1984): Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 293:305-311.
27. Hefti F, Hartikka J, Knusel B (1989): Function of neurotrophic factors in the adult and aging brain and their possible role in the treatment of neurodegenerative diseases. Neurobiol Aging 10:515-533.
28. Higgins GA, Koh S, Chen KS, Gage FH (1989): NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. Neuron 3:247-256.
29. Hoffman D, Breakefield XO, Short MP, Aebischer P (1993): Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol 122:100-106.
30. Jope RS (1979): High-affinity choline transport and acetylcoenzyme A production in brain and their roles in the regulation of acetylcholine synthesis. Brain Res 1:313-344.
31. Jorgensen OS (1995): Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling. Neurochem Res 20:533-547.
32. Kawaja MD, Rosenberg MB, Yoshida K, Gage FH (1992): Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J Neurosci 12:2849-2864.
33. Kordower JH, Winn SR, Liu YT, Mufson FJ, Sladek JR, Hammang JP, Baetge EE, Emerich DF (1994): The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 91:10898-10902.
34. Kromer LF (1987): Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214-216.
35. 3H]acetylcholine synthesis, [3H]acetylcholine release and choline acetyltransferase activity. Neuroscience 42:639-649.
36. Lapchak PA, Jenden DJ, Hefti F (1992): Pharmacological stimulation reveals NGF-induced elevations of in vivo hippocampal cholinergic function measured in rats with partial fimbrial transections. Neuroscience 50:847-856.
37. Leanza G, Nilsson OG, Wiley RG, Björklund A (1995): Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioral, biochemical and stereological studies. Eur J Neurosci 7:329-343.
38. Lehericy S, Hirsch EC, Cervera-Pierot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw J-J, Javoy-Agid F, Agid Y (1993): Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol 330:15-31.
39. Maysinger D, Piccardo P, Liberini P, Jalsenjak I, Cuello AC (1994): Encapulsated genetically engineered fibroblasts: release of nerve growth factor and effects in vivo on recovery of cholinergic markers after devascularizing cortical lesions. Neurochem Int 24:495-503.
40. McKinney M, Coyle JT (1991): The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. Mayo Clin Proc 66:1225-1237.
41. Mohiuddin L, Fernandez K, Tomlinson DR, Fernyhough P (1995): Nerve growth factor and neurotrophin-3 enhance neunte out-growth and up-regulate the levels of messenger RNA for growth-associated protein GAP-43 and alpha-tubulin in cultured adult rat sensory neurones. Neurosci Lett 185:20-23.
42. Montero CN, Hefti F (1986): Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J Neurosci 8:2986-2999.
43. Nabeshima T, Nitta A, Fuji K, Kameyama T, Hasegawa T (1994): Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesionedrats. Gerontology 40 (suppl. 2):46-56.
44. Nilsson OG, Leanza G, Rosenblad C, Lappi DA, Wiley RG, Bjorklund A (1992): Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. NeuroReport 3:1005-1008.
45. Palmer TD, Rosman GJ, Osbourne WRA, Miller AD (1991): Genetically modified skin fibroblasts persist long after transplantation but gradually inactive introduced genes. Proc Natl Acad Sci USA 88:1330-1334.
46. Pascual J, Fontan A, Zarranz JJ, Berciano J, Florez J, Pazos A (1991): High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia. Brain Res 552:170-174.
47. Paxinos G, Watson C (1986): "The Rat Brain in Stereotaxic Coordinates." New York: Academic Press.
48. Piccardo P, Maysinger D, Cuello AC (1992): Recovery of nucleus basalis cholinergic neurons by grafting NGF secretor fibroblasts. NeuroReport 3:353-356.
49. Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breakefield XO, Gage FH (1988): Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 242:1575-1578.
50. Roßner S, Perez-Polo JR, Wiley RG, Schliebs R, Bigl V (1994): Differential expression of immediate early genes in distinct layers of rat cerebral cortex after selective immunolesion of the forebrain cholinergic system. J Neurosci Res 38:282-293.
51. Roßner S, Härtig W, Schliebs R, Br̈ckner G, Brauer K, Perez-Polo JR, Wiley RG, Bigl V (1995a): 192 IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei. J Neurosci Res 41:335-346.
52. Roßner S, Schliebs R, Perez-Polor JR, Wiley RG, Bigl V (1995b): Differential changes in cholinergic markers after specific immunolesion of rat cholinergic basal forebrain system. J Neurosci Res 40:31-43.
53. Rupniak NMJ (1992): Profile of cholinomimetic drugs in primates: status of screens for potential Alzheimer therapies. Drug Dev Res 27:77-88.
54. Rylett RJ, Williams LR (1994): Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. TINS 17:486-490.
55. Schliebs R, Bigl V (1996): Animal models to produce cortical cholinergic dysfunction. In Perez-Polo JR (ed): "Methods in Neurosciences: Paradigms of Neural Injury." San Diego: Academic Press, pp 275-289.
56. Schliebs R, Zivin M, Steinbach J, Rothe T (1989): Changes in cholinergic but not GABAergic markers in amygdala, piriform cortex, and nucleus basalis of the rat brain following systemic administration of kainic acid. J Neurochem 53:212-218.
57. Schumacher JM, Short MP, Hyman BT, Breakefield XO, Isacson O (1991): Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45:561-570.
58. Skene JHP (1989): Axonal growth-associated proteins. Ann Rev Neurosci 12:127-156.
59. Smith G (1988): Animal models for Alzheimer's disease: experimental cholinergic denervation. Brain Res Rev 13:103-118.
60. Strömberg I, Wetmore JC, Ebendal T, Ernfors P, Persson H, Olson L (1990): Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J Neurosci Res 25:405-411.
61. Takei N, Tsukui H, Hatanaka H (1988): Nerve growth factor increases the intracellular content of acetylcholine in cultured septal neurons from developing rats. J Neurochem 51:1118-1125.
62. Torres EM, Perry TA, Blokland A, Wilkinson LS, Wiley RG, Lappi DA, Dunnett SB (1994): Behavioral, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 63:95-122.
63. Traub M, Freedman SB (1992): The implication of current therapeutic approaches for the cholinergic hypothesis of dementia. Dementia 3:189-192.
64. Trimble WS, Scheller RH (1988): Molecular biology of synaptic vesicle-associated proteins. TINS 11:241-242.
65. Tuszynski MH, Armstrong DM, Gage FH (1990a): Basal forebrain loss following fimbria/fornix transect ion. Brain Res 508:241-248.
66. Tuszynski MH, Buszaki G, Gage FH (1990b): Nerve growth factor infusions combined with fetal hippocampal grafts enhance reconstruction of the lesioned septohippocampal projection. Neuroscience 36:33-44.
67. Waite JJ, Wardlow ML, Chen AD, Lappi DA, Wiley RG (1994): Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporin. Neurosci Lett 169:154-158.
68. Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thal LJ (1995): 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience 65:463-476.
69. Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG (1994): Behavioral, biochemical, histological and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 14:5986-5995.
70. Westlund KN, Lu Y, Kadekaro M, Harmann P, Terrell ML, Pizzo DP, Hulsebosch CE, Eisenberg HM, Perez-Polo JR (1995): NGF-producing transfected 3T3 cells: behavioral and histological assessment of transplants in nigral lesioned rats. J Neurosci Res 41:367-373.
71. Wiley RG, Oeltmann TN, Lappi DA (1991): Immunolesioning: selective destruction of neurons using immunotoxin to NGF receptor. Brain Res 562:149-153.
72. Williams L, Varon S, Peterson G, Wictorin K, Fischer W, Björklund A, Gage FH (1986): Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 83:9231-9235.
73. Williams LR Jodelsi KS, Donald MR (1989): Axotomy-dependent stimulation of choline acetyltransferase activity by exogenous mouse nerve growth factor in adult rat basal forebrain. Brain Res 498:243-256.
74. Winkler J, Suhr ST, Gage FH, Thai LJ, Fisher LJ (1995): Essential role of neocortical acetylcholine in spatial memory. Nature 375:484-487.
75. Yu J, Pizzo D, Hutton L, Perez-Polo JR (1996a): The role of cholinergic system in neurotrophin synthesis. Brain Res 705:247-254.
76. Yu J, Wiley RG, Perez-Polo JR (1996b): Altered NGF protein levels in different brain areas after immunolesion. J Neurosci Res 43:213-223.